Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 1,736 filings

Top spenders & firms Spend by issue

Clear
Q3
LIBERTY PARTNERS GROUP, LLC for HONEST HEALTH
3rd Quarter (July 1 - Sep 30) 2025 · Tennessee · House · Senate
Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q3
THE ROOSEVELT GROUP for GUAM REGIONAL MEDICAL CITY
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $15,000.00 income
Medical/Disease Research/Clinical Labs, Defense
View →
Q3
AQUIA GROUP INC. (F.K.A. AQUIA GROUP LLC) for OMEROS CORPORATION
3rd Quarter (July 1 - Sep 30) 2025 · Washington · $90,000.00 income
Medical/Disease Research/Clinical Labs
View →
Q3
THE ROOSEVELT GROUP for LSU HEALTH SCIENCES FOUNDATION
3rd Quarter (July 1 - Sep 30) 2025 · Louisiana · House · Senate · $50,000.00 income
Defense, Medical/Disease Research/Clinical Labs, Health Issues
View →
Q3
THE VOGEL GROUP for TRUETEST MEDICAL
3rd Quarter (July 1 - Sep 30) 2025 · Idaho · $20,000.00 income
Medical/Disease Research/Clinical Labs, Consumer Issues/Safety/Products
View →
Q3
THE VOGEL GROUP for ALLENTOWN, INC
3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate · $45,000.00 income
Animals, Manufacturing, Medical/Disease Research/Clinical Labs
View →
Q3
HOLLAND & KNIGHT LLP for PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $70,000.00 income
Medical/Disease Research/Clinical Labs
View →
Q3
ALPINE GROUP PARTNERS, LLC. for MENTAL HEALTH AMERICA
3rd Quarter (July 1 - Sep 30) 2025 · Virginia · House · Senate · $10,000.00 income
Medicare/Medicaid, Medical/Disease Research/Clinical Labs, Health Issues, Budget/Appropriations
View →
Q3
SPIRIT ROCK CONSULTING for PECHANGA BAND OF LUISENO MISSION INDIANS
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $60,000.00 income
Gaming/Gambling/Casino, Indian/Native American Affairs, Taxation/Internal Revenue Code, Natural Resources
View →
Q3
ALSTON & BIRD LLP for TRAVERE THERAPEUTICS
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $70,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy, Medical/Disease Research/Clinical Labs
View →
Q3
O'NEILL AND ASSOCIATES for POINT32HEALTH SERVICES, INC. (FORMERLY TUFTS HEALTH PLAN)
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $15,000.00 income
Medical/Disease Research/Clinical Labs
View →
Q3
O'NEILL, ATHY & CASEY, P.C. for MASS GENERAL BRIGHAM
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $50,000.00 income
Medicare/Medicaid, Health Issues, Medical/Disease Research/Clinical Labs, Budget/Appropriations
View →
Q3
FORWARD GLOBAL for QUOIN PHARMACEUTICALS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Virginia · House · Senate · $20,000.00 income
Health Issues, Medical/Disease Research/Clinical Labs, Pharmacy
View →
Q3
CALIFORNIA LIFE SCIENCES for CALIFORNIA LIFE SCIENCES
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate
Budget/Appropriations, Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q3
NAVIGATORS GLOBAL LLC (FORMERLY DC NAVIGATORS, LLC) for SOLVENTUM
3rd Quarter (July 1 - Sep 30) 2025 · Minnesota · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid, Science/Technology, Trade (domestic/foreign)
View →
Q3
MICHAEL BEST STRATEGIES LLC for SAREPTA THERAPEUTICS
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $110,000.00 income
Health Issues, Medical/Disease Research/Clinical Labs
View →
Q3
O'NEILL, ATHY & CASEY, P.C. for HARVARD UNIVERSITY
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $40,000.00 income
Medicare/Medicaid, Medical/Disease Research/Clinical Labs, Budget/Appropriations, Taxation/Internal Revenue Code
View →
Q3
CYSTIC FIBROSIS FOUNDATION for CYSTIC FIBROSIS FOUNDATION
3rd Quarter (July 1 - Sep 30) 2025 · Maryland · House · Senate
Health Issues, Insurance, Budget/Appropriations, Medical/Disease Research/Clinical Labs
View →
Q3
STEPTOE LLP for VELICO MEDICAL INC.
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $60,000.00 income
Medical/Disease Research/Clinical Labs, Disaster Planning/Emergencies
View →
Q3
THE VOGEL GROUP for HDT BIO CORP
3rd Quarter (July 1 - Sep 30) 2025 · Washington · House · Senate · $49,500.00 income
Health Issues, Medical/Disease Research/Clinical Labs, Science/Technology
View →
Q3
AMERICANS FOR RESPONSIBLE INNOVATION for AMERICANS FOR RESPONSIBLE INNOVATION
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Trade (domestic/foreign), Computer Industry, Science/Technology, Budget/Appropriations
View →
Q3
COVINGTON & BURLING LLP for AMERICAN CLINICAL LABORATORY ASSOCIATION (ACLA)
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · $40,000.00 income
Medical/Disease Research/Clinical Labs
View →
Q3
AMERICAN ACADEMY OF PHYSICAL MEDICINE AND REHABILITATION for AMERICAN ACADEMY OF PHYSICAL MEDICINE AND REHABILITATION
3rd Quarter (July 1 - Sep 30) 2025 · Illinois · House · Senate
Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q3
PATIENTSACT for PATIENTSACT
3rd Quarter (July 1 - Sep 30) 2025 · Illinois
Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
RR
SALUBER STRATEGIES for PATIENTS ACT
3rd Quarter (July 1 - Sep 30) 2025 · Illinois
Medicare/Medicaid, Medical/Disease Research/Clinical Labs
View →
Previous Page 31 of 70 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem